SCIENTURE HOLDINGS, INC. Business Acquisition, Pro Forma Net Income (Loss)
SCIENTURE HOLDINGS, INC. (SCNX) reported Business Acquisition, Pro Forma Net Income (Loss) of $159.25 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2020-03-30
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2019-03-31 was $159.25K.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-12-31 was -$175.50K.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-09-30 was $203.81K.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-06-30 was $8.33K.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2018 was $118.90K, a 47.35% decline from fiscal 2017.
- SCIENTURE HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2017 was $225.85K.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2019-03-31 | $159.25K 10-Q · filed 2019-05-13 | -$16.25K derived: sum of 2 quarters · filed 2020-03-30 | $187.56K derived: sum of 3 quarters · filed 2020-03-30 | $195.89K derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-12-31 | -$175.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $28.31K derived: sum of 2 quarters · filed 2020-03-30 | $36.63K derived: sum of 3 quarters · filed 2020-03-30 | $118.90K 10-K · filed 2020-03-30 |
| 2018-09-30 | $203.81K 10-Q · filed 2019-10-28 | $212.13K derived: sum of 2 quarters · filed 2019-10-28 | $294.40K 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $8.33K 10-Q · filed 2019-07-26 | $167.58K 10-Q · filed 2019-07-26 | ||
| 2017-12-31 | $225.85K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |